Skip to main content
. Author manuscript; available in PMC: 2014 Aug 18.
Published in final edited form as: Cancer Chemother Pharmacol. 2011 Apr 12;68(6):1469–1475. doi: 10.1007/s00280-011-1623-y

Fig. 2.

Fig. 2

Dose-effect plots illustrating the interaction between CEP-701 and 13cRA in the a SH-SY5Y-BR6, b SH-SY5Y, c IMR-5, d CHP-134, and e E6-NBLS cell lines. ○ CEP-701, □ CEP-701 and 1 microM 13cRA, ◇ CEP-701 and 5 microM 13cRA, × CEP-701 and 10 microM 13cRA